FDA Approves GABAPENTIN — Zhejiang Yongtai Pharmaceutical Co., Ltd

# FDA Approves Generic Gabapentin from Zhejiang Yongtai Pharmaceutical The U.S. Food and Drug Administration has approved Zhejiang Yongtai Pharmaceutical Co., Ltd.'s generic formulation of gabapentin, adding competitive pressure to the oral gabapentin market and potentially reducing treatment costs for patients managing neuropathic pain and seizure disorders. The approval of ANDA213603 expands the generic gabapentin landscape, likely to intensify price competition among existing manufacturers and further erode branded drug pricing power in this established therapeutic category.